¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Alpha heavy chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • complicating disease
    ÇÕº´Áúȯ
  • compressed-air disease
    °¨¾Ðº´
  • congenital heart disease
    ¼±Ãµ½ÉÀ庴
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • constitutional disease
    üÁúº´
  • constrictive heart disease
    ÇùÂø½ÉÀ庴
  • contagious disease
    Á¢ÃËÀü¿°º´
  • carcinoid heart disease
    Ä«¸£½Ã³ëÀ̵å½ÉÀ庴
  • copper storage disease
    ±¸¸®ÃàÀûº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • cold hemagglutinin disease
    Àú¿ÂÇ÷±¸ÀÀÁý¼Òº´, ÇÑ·©ÀûÇ÷±¸ÀÀÁýº´
  • collagen disease
    ¾Æ±³Áúº´
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • complicating disease
    ÇÕº´Áõ
  • compressed-air disease
    °¡¾Ðº´
  • congenital heart disease
    ¼±Ãµ½ÉÀ庴
  • connate disease
    ¼±Ãµº´
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • constitutional disease
    üÁúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • alpha-ketoglutarate
    ¾ËÆÄ-ÄÉÅä±Û·çŸ·¹ÀÌÆ®
  • alpha-l-iduronidase
    a-L-Iduronidase
  • alpha-lipoproteinemia
    ¾ËÆÄ-Áö¹æ´Ü¹éÇ÷Áõ
  • alpha-naphthyl acetate esterase
    ¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
  • alpha-naphthyl acetate esterase =ANAE
    ¾ËÆÄ¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
  • alpha-naphthyl butyrate esterase
    ¾ËÆÄ-³ªÇÁÆ¿ ºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
  • alpha-naphthyl butyrate esterase =ANBE
    ¾ËÆÄºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
  • alpha-naphthylamine
    ¾ËÆÄ-³ªÇÁÆ¿¾Æ¹Î
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • alpha-thalassemia trait
    ¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • galactosidase, alpha-galactosidase a, deficiency
    #NAME?
  • glucosidase, alpha -1,4-glucosidase
    -1,4-±Û·çÄڽõ¥À̽º
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • inter-alpha-trypsin inhibitor
    ÀÎÅÍ-¾ËÆÄ-Æ®¸³½Å ¾ïÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • alpha-naphthyl butyrate esterase =ANBE
    ¾ËÆÄºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
  • alpha-naphthylamine
    ¾ËÆÄ-³ªÇÁÆ¿¾Æ¹Î
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • alpha-thalassemia trait
    ¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • angle alpha
    ¾ËÆÄ°¢
  • cowpea(alpha-borne) mosaic virus
    Ä«¿ìÇÇ ¸ðÀÚÀÌÅ©¹ÙÀÌ·¯½º
  • galactosidase, alpha-galactosidase a, deficiency
    #NAME?
  • glucosidase, alpha -1,4-glucosidase
    -1,4-±Û·çÄڽõ¥À̽º
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • inter-alpha-trypsin inhibitor
    ÀÎÅÍ-¾ËÆÄ-Æ®¸³½Å ¾ïÁ¦Á¦
  • mannosidase, alpha-mannosidase, deficiency
    #NAME?
  • reductase, 5-alpha-reductase inhibitor
    5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡­ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡­åäð¤ð¥)
  • retinoid acid receptor alpha=RARA
    ¾ËÆÄ·¹Æ¼³ëÀÍ»ê¼ö¿ëü
  • streptococcus, alpha (¥á) hemolytic
    ¾ËÆÄ¿ëÇ÷ ¿¬¼â±¸±Õ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • DNA polymerase chain reaction
    DNA Æú¸®¸Ó·¹À̽º ¿¬¼â ¹ÝÀÀ(ææáðÚãëë) (ÔÒ) polymerase chain reaction
  • electron transfer chain
    ÀüÀÚÀü´Þ(ï³í­îîÓ¹) »ç½½
  • electron transport chain
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) »ç½½
  • end carbon chain
    ³¡Åº¼Ò(÷©áÈ) »ç½½
  • epsilon chain
    ÀԽǷР»ç½½
  • equivalent chain length
    µî(Ôõ)»ç½½ ±æÀÌ
  • food chain
    ¸ÔÀÌ »ç½½
  • gamma chain
    °·¸¶ »ç½½
  • Gaussian chain
    °¡¿ì½º »ç½½
  • H chain
    H »ç½½
  • immunoglobulin chain
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° »ç½½
  • J chain
    J »ç½½
  • kappa chain
    Ä«ÆÄ»ç½½
  • lambda chain
    ¶÷´Ù »ç½½
  • L-chain
    L»ç½½
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ITIL inter-alpha-trypsin inhibitor, light chain
TSHA thyroid-stimulating hormone, alpha chain
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
ARD absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
BCKDH Branched chain alpha-ketoacid dehydrogenase
BCKD branched chain alpha-ketoacid dehydrogenase
1 alpha(OH)D3 1 alpha hydroxyvitamin D3
1 alpha,25(OH)2D3 1 alpha, 25 dihydroxyvitamin D3
1 alpha,25(OH)2D 1 alpha,25 dihydroxyvitamin D
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Bernhardt's disease
    º£¸¥Çϸ£Æ® º´
    µ¿ÀǾî=meralgia
  • Best's disease
    º£½ºÆ® º´
    µ¿ÀǾî=congenital macular degeneration.
  • black disease
    Èæ»ö º´
    ¾çÀÇ Àü¿°¼º ±«»ç¼º °£¿°. ¹Ì±¹, ¿À½ºÆ®·¹Àϸ®¾Æ¿¡¼­ÀÇ ¾çÀÇ Ä¡»çº´ÀÌ¸ç ¶§¶§·Î »ç¶÷¿¡°Ôµµ »ý±ä´Ù. °£ÀåÀÇ ±«»ç°¡ ±× Ư¡ÀÌ¸ç ³ëºñ±Õ¿¡ ÀÇÇÏ¿© ÀϾ´Ù.
  • bleeder's disease
    Ç÷¿ìº´
    ÃâÇ÷À» Àß ÀÏÀ¸Å°°Å³ª ÃâÇ÷ ¼ÒÁúÀÌ ÀÖ´Â Áúº´.
  • Blocq's disease
    ºí·Ï º´
    µ¿ÀǾî=astasia, abasia.
  • blood disease
    Ç÷¾× ÀÌ»ó
    µ¿ÀǾî=hemic disease.
  • bone disease
    °ñ Áúȯ
    µ¿ÀǾî=osteo
  • Bowen's disease
    º¸À¢ º´, º¸À¢ Áúȯ
    1. À¯¿øÇüÀÇ °æ°è. ¼±¸íÇÑ Èë°¥»ö ³»Áö °¥»öÀÇ ±¹¼ÒÀû º´º¯À» Çü¼ºÇÑ´Ù. ±¸°­ Á¡¸·ÀÇ Àû»ö, ¹é»ö ¹ÝÁ¡À¸·Î ¶Ñ·ÇÇÑ ºÒ±ÔÄ¢ÇÑ ¼ºÀåÀ» ÇÑ´Ù. °¡Çǰ¡ µ¤È÷¸é¼­ ¿ø½É»óÀ¸·Î È®´ëÇϴµ¥ Ç¥ÇÇ ³»¾ÏÀÇ »óŸ¦ À¯ÁöÇÏ¸ç ±âÀúÃþ¿¡ ÆÄ±«, Áõ½Ä, ÀüÀ̸¦ ³ªÅ¸³»´Â °ÍÀº »ó´çÈ÷ ÁøÇàÇÑ °æ¿ìÀÌ´Ù. Ä¡·á¹ýÀ¸·Î¼­´Â ÀýÁ¦, Ç×¾ÏÁ¦ ¿¬°í°¡ »ç¿ëµÈ´Ù. 2. ³»Àå ¾Ï°ú °ü·Ã ÀÖ´Â ºñħÀ±¼º ¾ÏÁ¾À¸·Î µå¹°°Ô ¹ß»ýÇÏ¸ç ³²¼º, ¿©¼º ¸ðµÎ ¼º±â¿¡ ¹ß»ýÇÑ´Ù. 3. »óÇdz»ÀÇ ¾Ç¼º Á¾¾çÀÌ´Ù. ¾Ç¼º ¼ºÀåÀº °Ç°­ÇÑ ±âÀú¸·°ú ÇÔ²² »óÇÇ¿¡ Á¦ÇѵȴÙ. ÇǺδ ¸î °³ÀÇ À¶±âµÈ Á¡À» µ¿¹ÝÇÑ Ã¤ ºÓ°Ô ³ªÅ¸³ª¸ç ºÎºÐÀûÀ¸·Î Àμ³ÀÌ Çü¼ºµÇ¾î ÀÖ°í ºÎºÐÀûÀ¸·Î Á¥¾î ÀÖ´Ù. Áß¾Ó¿¡ À§ÃàÀ̳ª ±Ë¾çÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 4. ºñ±³Àû µå¹® ÁúȯÀ¸·Î ³ëÃâ ¶Ç´Â ºñ³ëÃâ ºÎÀ§¿¡ »ý±æ ¼ö ÀÖ´Ù. º´º¯Àº ÀÛ°í
  • Brill-Zinsser disease
    Brill-Zinsser º´
    ¹ßÁøÆ¼Çª½º¿¡ °É·È´ø ȯÀÚ¿¡¼­ ¹ß»ýµÇ´Â Àç¹ßÇüÀÇ º´À¸·Î ¸®ÄÉÄ¡¾Æ±ÕÀº º´ÀÌ ³ªÀº ÈÄ¿¡µµ ¼ö ½Ê³â°£ Áõ»ó ¾øÀÌ ¸²ÇÁÀý ¼Ó¿¡ Á¸¼ÓÇÒ ¼ö ÀÖ´Ù.
  • Buergers disease
    ¹ö°Å º´
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • bullous skin disease
    ¼öÆ÷¼º ÇǺΠÁúȯ
  • calcific mitral disease
    ¼®È¸È­ ½Â¸ðÆÇ¸· Áúȯ
  • caloric disease
    °í¿Â º´
    °í¿Â¿¡ ³ëÃâµÇ¾î ³ªÅ¸³ª´Â Áúȯ.
  • Canavan's disease
    Ä«³ª¹Ý º´
    »ó¿°»öü ¿­¼º À¯ÀüÇÏ´Â ÁúȯÀ¸·Î ¾Æ½ºÆÄ¸£Å侯½Ç¶óÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
immunoglobulins, mu-chain Heavy chains found in the fab and fc fragments of IgM and having a molecular weight of approximately 72 kD. They contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG.
(12 Dec 1998)
invariant chain <chemical> Noncovalently associated with class II antigens, alpha and beta chain complex; involved in the regulation of malignant cell ia function; iip31 and iip33 were synthesized by using alternative initiator methionines
Synonym: II igc, ia-associated invariant chain, II invariant glycoprotein complex, class II-associated invariant chain, IIp33, IIp31, clip peptide, ln-2 antigen, ln 2 antigen, cd74 antigen, II-key, II76-92
(05 Dec 1998)
open chain compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
ossicular chain The small bones of the middle ear; they are articulated to form a chain for the transmission of sound from the tympanic membrane to the oval window.
Synonym: ossicula auditus, ear bones, ossicular chain.
(05 Mar 2000)
EDTA light chain <protein> Myosin light chains (18 kD) from scallop muscle (two per pair of heavy chains), easily extracted by calcium chelation. Although the EDTA light chains do not bind calcium they confer calcium sensitivity on the myosin heavy chains.
(18 Nov 1997)
electron transport chain <biochemistry, chemistry> A series of compounds that transfer electrons to an eventual donor with concomitant energy conversion.
One of the best studied is in the mitochondrial inner membrane, that takes NADH (from the tricarboxylic acid cycle) or FADH and transfers electrons via ubiquinone, cytochromes and various other compounds, to oxygen. Other electron transport chains are involved in photosynthesis.
(18 Nov 1997)
J chain <molecular biology> A polypeptide chain (15 kD), found in IgA and in IgM joining heavy chains (H chains) to each other to form dimers of IgA and pentamers of IgM. Disulphide bonds are formed between the J chain and H chains near the Fc ends of the heavy chains. Despite the similar name, it is not identical with the J region or coded for by the J gene.
Synonym: J piece.
(10 Jan 1998)
kappa chain <protein> Either of two types of light chains (small polypeptide chains) that are found in immunoglobulins.
(09 Oct 1997)
2-methyl branched-chain enoyl-CoA reductase <enzyme> Important in the reversal of beta-oxidation under anaerobic conditions in ascaris suum
Registry number: EC 1.3.1.52
Synonym: 2-methyl bce-CoA reductase
(26 Jun 1999)
lambda chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
lauric acid in-chain-hydroxylase <enzyme> Specific for lauric acid; hydroxylates at c-8, c-9 or c-10 of chain
Registry number: EC 1.14.14.-
Synonym: (cytochrome p-450)-dependent laurate in-chain-hydroxylase
(26 Jun 1999)
L chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
L-chain myeloma bence Jones myeloma
light chain <immunology, protein> The lighter of the two types of polypeptide chains that are found in immunoglobulin and antibody molecules.
Also used as a non-specific term for the smaller subunits of several multimeric proteins such as immunoglobulin, myosin, dynein, clathrin.
(14 Oct 1997)
light chain-related amyloidosis A form of primary amyloidosis in which the fibrillar amyloid deposits are derived from the amino terminal variable region of the light chains of immunoglobulin; seen in B-lymphocyte and plasma-cells dyscrasias.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • GVH disease
    ´ë¼÷ÁÖ¼º ÀÌ½ÄÆíº´
  • Graves' disease
    ±×·¹À̺êÁî(¹ÙÁ¦µµ)º´
  • Hansens disease
    ÇѼ¾º´;¹®µÕº´
  • Hashimoto's disease
    ÇϽø𵵺´;¸¸¼º °©»ó¼±¿°(°©»ó¼± ±â´ÉÀÌ ÀúÇϵǴ Áúȯ)
  • Hodgkin's disease
    È£ÁöŲ º´(¾Ç¼º À°¾ÆÁ¾Áß)
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´(°í¿­,ÃâÇ÷ µ¿¹Ý)
  • Newcastle disease
    ´ºÄ³½½º´(¼³»ç,È£Èí °ï¶õÀ» ÁÖ·Î ÇÏ´Â ¹ÙÀÌ·¯½º¼º °¡±Ýº´)
  • Raynaud's disease
    ·¹À̳뺴(·¹À̳ë Çö»ó ¹ßÀÛÀ» Ư¡À¸·ÎÇÏ´Â Ç÷°ü Àå¾Ö)
  • Riggs' disease
    Ä¡Á¶ ³ó·ç
  • atomic disease
    ¿øÀÚº´
  • atonic disease
    ¿øÀÚº´
  • basedows disease
    ¹ÙÁ¦µµ º´
  • caisson disease
    ÄÉÀ̽¼º´;ÀáÇÔº´
  • celiac disease
    ¼Ò¾ÆÁö¹æº¯Áõ
  • deficiency disease
    ¿µ¾ß ½ÇÁ¶;ºñŸ¹Î °áÇÌÁõ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á